ÐÇ¿Õ´«Ã½

Annual report pursuant to Section 13 and 15(d)

STOCK COMPENSATION PLANS (Tables)

v3.22.0.1
STOCK COMPENSATION PLANS (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract] Ìý
Summary of Total Compensation Expense Recognized for Stock-Based Compensation Awards
The following table summarizes the total compensation expense recognized for stock-based compensation awards:
(InÌýMillions,Ìýexcept per
shareÌýamounts)
Year Ended December 31,
Ìý 2021 2020 2019
Cost of goods sold $ (2) $ (2) $ (2)
Selling, general and administrative expenses (16) (13) (16)
Acquisition-related costs —Ìý (2) —Ìý
Stock based compensation expense (18) (17) (18)
Income tax benefit 4Ìý 4Ìý 4Ìý
Stock based compensation expense, net of tax $ (14) $ (13) $ (14)
Decrease in basic earnings per common share $ (0.03) $ (0.03) $ (0.05)
Decrease in diluted earnings per common share $ (0.03) $ (0.03) $ (0.05)
Summary of Performance Award Activity
The following table summarizes the performance award activity:
Year Ended December 31,
2021 2020 2019
Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value
Outstanding at beginning of year 2,452,226Ìý $ 10.34Ìý 1,935,878Ìý $ 15.58Ìý 1,424,723Ìý $ 14.46Ìý
Granted 652,888Ìý 25.12Ìý 960,637Ìý 6.93Ìý 572,104Ìý 18.31Ìý
Granted - replacement awards —Ìý —Ìý 1,550,216Ìý 4.59Ìý —Ìý —Ìý
Distributed (1,279,509) 11.74Ìý (1,938,786) 12.23Ìý —Ìý —Ìý
Performance adjustment 625,355Ìý 11.93Ìý 549,154Ìý 15.63Ìý —Ìý —Ìý
Forfeited/canceled (80,490) 11.27Ìý (604,873) 5.70Ìý (60,949) 15.12Ìý
Outstanding at end of year 2,370,470Ìý $ 14.04Ìý 2,452,226Ìý $ 10.34Ìý 1,935,878Ìý $ 15.58Ìý
Summary of Restricted Stock Unit Activity
The following table summarizes the restricted stock units activity:
Year Ended December 31,
2021 2020 2019
Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value
Outstanding at beginning of year 2,143,583Ìý $ 7.12Ìý 2,147,183Ìý $ 9.10Ìý 4,694,360Ìý $ 4.18Ìý
Granted 678,420Ìý 17.45Ìý 960,637Ìý 4.87Ìý 572,104Ìý 11.24Ìý
Granted - replacement awards —Ìý —Ìý 200,291Ìý 4.87Ìý —Ìý —Ìý
Distributed (642,992) 7.31Ìý (1,101,115) 8.58Ìý (3,058,307) 1.95Ìý
Forfeited/canceled (56,185) 9.50Ìý (63,413) 7.31Ìý (60,974) 9.31Ìý
Outstanding at end of year 2,122,826Ìý $ 10.31Ìý 2,143,583Ìý $ 7.12Ìý 2,147,183Ìý $ 9.10Ìý
Summary of Stock Option Activity
The following table summarizes the stock option activity:
Year Ended December 31,
2021 2020 2019
Number of Shares Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price
Outstanding at beginning of year 2,485,808Ìý $ 11.60Ìý 563,230Ìý $ 10.42Ìý 563,230Ìý $ 10.42Ìý
Granted - replacement awards —Ìý —Ìý 2,010,277Ìý 11.86Ìý —Ìý —Ìý
Exercised (1,457,495) 10.36Ìý (79,973) 7.01Ìý —Ìý —Ìý
Forfeited/canceled (26,253) 36.48Ìý (7,726) 41.04Ìý —Ìý —Ìý
Outstanding at end of year 1,002,060Ìý $ 12.75Ìý 2,485,808Ìý $ 11.60Ìý 563,230Ìý $ 10.42Ìý
Exercisable at end of year 904,574Ìý $ 13.35Ìý 2,172,052Ìý $ 11.86Ìý 563,230Ìý $ 10.42Ìý
Summary of Grants of Restricted and/or Deferred Shares to Nonemployee Directors
For the last three years, grants of restricted and/or deferred shares have been awarded to elected or re-elected nonemployee directors as follows:
Year of Grant Restricted Shares Deferred Shares
2021 58,851Ìý 13,078Ìý
2020 253,809Ìý 54,794Ìý
2019 86,477Ìý 23,659Ìý